Shandong Realcan Pharmaceutical Co Ltd (002589) — Capital Reinvestment Ratio
Shandong Realcan Pharmaceutical Co Ltd (002589) has a Capital Reinvestment Ratio of 2.12x as of June 2025, meaning it reinvests 2% of its operating cash flow (CN¥24.86 Million) in capital expenditures (CN¥52.73 Million). See how leveraged is Shandong Realcan Pharmaceutical Co Ltd's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Realcan Pharmaceutical Co Ltd Capital Reinvestment Ratio (2009–2024)
This chart tracks Shandong Realcan Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 8 annual periods. Check 002589 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shandong Realcan Pharmaceutical Co Ltd (2009–2024)
Year-by-year Capital Reinvestment Ratio for Shandong Realcan Pharmaceutical Co Ltd from 2009 to 2024. For live market cap and broader valuation context, see 002589 market cap overview.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.70x | CN¥160.44 Million | CN¥111.53 Million | ▼ -80.8% |
| 2023 | 3.62x | CN¥82.47 Million | CN¥298.38 Million | ▲ +1007.0% |
| 2022 | 0.33x | CN¥523.07 Million | CN¥170.96 Million | ▼ -68.6% |
| 2021 | 1.04x | CN¥442.95 Million | CN¥461.09 Million | ▼ -14.5% |
| 2020 | 1.22x | CN¥414.96 Million | CN¥505.39 Million | ▲ +172.9% |
| 2019 | 0.45x | CN¥2.09 Billion | CN¥934.87 Million | ▼ -16.5% |
| 2010 | 0.53x | CN¥70.56 Million | CN¥37.72 Million | ▲ +70.6% |
| 2009 | 0.31x | CN¥61.38 Million | CN¥19.23 Million | — |